Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.0K
3.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>meso</i>-Substitution controlled synthesis of BODIPY-DPM conjugates: a pathway to tailored photophysical properties.

Chemical communications (Cambridge, England)·2026
Same author

Engineering ECM-mimetic scaffolds from biological macromolecules for physiologically relevant tumoroid models.

Biomaterials advances·2026
Same author

Reprogramming Wound Healing: GAG-Based Bioactive Scaffold Drives Pro-Regenerative Cellular Cross-Talk.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
Same author

Formulation and administration timing of lipid derivatized JAK-inhibitor and corticosteroid modulate saRNA-LNP inflammation and expression.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Bridging neurotransmission and tumor biology: the emerging focus on CHRM1 in skin cancer therapy.

Expert opinion on therapeutic targets·2026
Same author

Shedding light on photo-redox catalysis of a NIR iridium(III) complex for high photocytotoxicity against cisplatin resistant ovarian cancer in 3D tumor spheroids.

Journal of materials chemistry. B·2026
Same journal

Engineering Functional Graphenic Materials for Bone Repair.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Breaking Through the Limits: Nanomedicine at the Service of New Drug Combinations to Tackle Pancreatic Cancer.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Advances in Engineered Virus-Like Particles for Applications in Nanomedicine.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Lipid- and Polymer-Based Nanoscale Delivery of Anti-Aging Phytochemicals.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Nano-Enabled Toxicity of Pharmaceutical Excipients.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Advances in Self-Assembly Artificial Chaperone for Protein Folding Regulation.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K

Modifying the tumor microenvironment using nanoparticle therapeutics.

Aniruddha Roy1, Shyh-Dar Li2

  • 1Department of Pharmacy, Birla Institute of Technology & Science (BITS), Pilani, India. aniruddha.roy@pilani.bits-pilani.ac.in.

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|April 3, 2016
PubMed
Summary
This summary is machine-generated.

Cancer tumors involve complex interactions between neoplastic and non-neoplastic stromal cells. Targeting these stromal components with nanoparticle-mediated drug delivery offers a promising strategy for effective cancer treatment.

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.4K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.7K

Related Experiment Videos

Last Updated: Mar 23, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.4K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.7K

Area of Science:

  • Oncology
  • Nanomedicine
  • Biotechnology

Background:

  • Cancer treatment evolved from radical surgeries to multimodality approaches.
  • Historically, cancer was viewed as a monocellular disorder, limiting treatment efficacy.
  • Recent research reveals tumors as complex networks involving neoplastic and non-neoplastic stromal cells.

Purpose of the Study:

  • To review the role of stromal components in tumor progression.
  • To discuss nanoparticle-mediated drug targeting strategies for stromal depletion.
  • To explore future directions in targeting tumor stroma.

Main Methods:

  • Review of current literature on tumor-stromal interactions.
  • Analysis of nanoparticle-mediated drug delivery systems for stromal targeting.
  • Discussion of therapeutic implications of disrupting tumor-stromal balance.

Main Results:

  • Stromal cells significantly contribute to tumor survival and progression.
  • Disrupting the tumor-stromal balance can impact tumor survival.
  • Nanoparticle-mediated drug targeting offers innovative approaches to deplete stromal components.

Conclusions:

  • Targeting tumor stroma represents a promising therapeutic strategy.
  • Nanomedicine provides novel tools for stromal depletion.
  • Further research into tumor-stromal interactions is crucial for advancing cancer treatment.